Cancer Immunotherapy Using AIRE Conditioning of the Tumor Epitopeome.

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• T cell immune tolerance is crucial for preventing autoimmunity.
• The Auto-immune Regulator (AIRE) transcription factor in thymic epithelial cells establishes tolerance by inducing self-antigen expression.
• Tumors can evade immune detection by mimicking self-tolerance mechanisms.

Purpose of the Study:

• To investigate if tumors utilize AIRE's mechanism to evade immune rejection.
• To develop a novel immunotherapy based on manipulating AIRE expression in tumor cells.
• To assess the potential of AIRE-mediated immunotherapy in treating non-immunogenic tumors.

Main Methods:

• Analysis of tumor expression of self-antigens.
• Engineering tumor cells to alter AIRE expression profiles.
• Assessing T cell responses to modified and parental tumor cells.
• Correlating AIRE expression with patient immune therapy response using RNA sequencing data.

Main Results:

• Tumors were found to mimic AIRE's role in establishing immune tolerance, effectively cloaking themselves from T cell attack.
• A novel immunotherapy was developed by engineering AIRE expression in tumor cells, altering their "selfishness" profile.
• AIRE expression in tumors correlates with patient response to immune therapies, specifically with T cell receptor signaling markers.
• AIRE-mediated immunotherapy converts tolerized T cells into tumor-reactive populations and sensitizes non-immunogenic tumors to immune checkpoint blockade.

Conclusions:

• Tumors exploit AIRE's self-tolerance mechanism for immune evasion.
• Modulating AIRE expression in cancer cells represents a novel immunotherapy strategy.
• This AIRE-mediated approach can overcome tumor-induced tolerance and enhance anti-tumor immunity, even for previously unresponsive cancers.